Free Trial

CONMED (CNMD) Competitors

CONMED logo
$54.52 +0.78 (+1.46%)
As of 09:59 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CNMD vs. MMSI, IRTC, GKOS, BLCO, TMDX, SLNO, NVST, LIVN, WRBY, and INSP

Should you be buying CONMED stock or one of its competitors? The main competitors of CONMED include Merit Medical Systems (MMSI), iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), and Inspire Medical Systems (INSP).

CONMED vs. Its Competitors

Merit Medical Systems (NASDAQ:MMSI) and CONMED (NYSE:CNMD) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.

In the previous week, Merit Medical Systems had 18 more articles in the media than CONMED. MarketBeat recorded 26 mentions for Merit Medical Systems and 8 mentions for CONMED. CONMED's average media sentiment score of 1.38 beat Merit Medical Systems' score of 1.27 indicating that CONMED is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
17 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CONMED
7 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Merit Medical Systems currently has a consensus target price of $107.00, indicating a potential upside of 18.32%. CONMED has a consensus target price of $59.80, indicating a potential upside of 10.19%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, equities research analysts clearly believe Merit Medical Systems is more favorable than CONMED.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89
CONMED
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.20

CONMED has lower revenue, but higher earnings than Merit Medical Systems. CONMED is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Merit Medical Systems$1.36B3.95$120.36M$1.9745.91
CONMED$1.33B1.27$132.42M$3.5315.37

Merit Medical Systems has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500. Comparatively, CONMED has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500.

99.7% of Merit Medical Systems shares are owned by institutional investors. 3.2% of Merit Medical Systems shares are owned by insiders. Comparatively, 3.1% of CONMED shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Merit Medical Systems' return on equity of 15.07% beat CONMED's return on equity.

Company Net Margins Return on Equity Return on Assets
Merit Medical Systems8.31% 15.07% 8.60%
CONMED 8.31%14.43%6.05%

Summary

Merit Medical Systems beats CONMED on 11 of the 15 factors compared between the two stocks.

Get CONMED News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CNMD vs. The Competition

MetricCONMEDMED/DENTAL IndustryMedical SectorNYSE Exchange
Market Cap$1.68B$15.18B$5.77B$21.29B
Dividend Yield1.46%1.48%3.95%3.51%
P/E Ratio15.3717.7331.2729.34
Price / Sales1.272.53440.2650.79
Price / Cash8.1016.2837.7323.86
Price / Book1.683.7310.615.39
Net Income$132.42M$472.13M$3.27B$996.59M
7 Day Performance-2.83%-1.87%1.41%0.41%
1 Month Performance7.77%-2.28%6.20%3.49%
1 Year Performance-26.67%5.61%50.13%12.09%

CONMED Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CNMD
CONMED
4.389 of 5 stars
$54.27
+1.0%
$59.80
+10.2%
-24.1%$1.68B$1.33B15.373,900News Coverage
Positive News
MMSI
Merit Medical Systems
4.4822 of 5 stars
$86.16
+0.8%
$107.00
+24.2%
-6.0%$5.06B$1.43B43.747,400Positive News
IRTC
iRhythm Technologies
1.3344 of 5 stars
$157.93
-1.7%
$157.30
-0.4%
+150.1%$5.16B$591.84M0.002,000Positive News
Analyst Forecast
GKOS
Glaukos
4.7294 of 5 stars
$89.47
-0.4%
$127.42
+42.4%
-28.7%$5.15B$383.48M0.00780
BLCO
Bausch + Lomb
1.1919 of 5 stars
$14.49
-0.4%
$15.56
+7.4%
-9.5%$5.15B$4.79B34.6413,500
TMDX
TransMedics Group
2.8846 of 5 stars
$125.65
-1.5%
$123.00
-2.1%
-30.9%$4.35B$441.54M66.09210Positive News
SLNO
Soleno Therapeutics
4.5659 of 5 stars
$68.09
-4.9%
$114.30
+67.9%
+45.5%$3.81BN/A0.0030News Coverage
Analyst Forecast
NVST
Envista
3.7069 of 5 stars
$20.75
+0.5%
$20.92
+0.9%
+15.8%$3.43B$2.51B24.0012,300Positive News
LIVN
LivaNova
1.6253 of 5 stars
$53.27
-0.8%
$59.29
+11.3%
+14.7%$2.93B$1.25B16.792,900Positive News
WRBY
Warby Parker
2.1384 of 5 stars
$27.38
+0.9%
$24.06
-12.1%
+71.1%$2.85B$771.32M-391.093,780Positive News
INSP
Inspire Medical Systems
4.9458 of 5 stars
$88.28
+0.6%
$165.62
+87.6%
-50.1%$2.60B$802.80M38.161,246Positive News

Related Companies and Tools


This page (NYSE:CNMD) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners